Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pre-eclampsia (PE) contributes to poor maternal morbidity and mortality. Progesterone is hypothesised to reduce the risk of PE. To determine the effect of progestogen supplementation during assisted reproductive technique (ART) in reducing the incidence of PE. A retrospective comparative analysis among 1140 pregnancies between January 2006 and March 2015 conducted in a tertiary centre. A total of 570 pregnancies who conceived following ART with progesterone supplementation (study group) and an age-matched spontaneous pregnancies, without progesterone supplementation (control group, n=570) were included in the analysis. The study group received progesterone support following ART or intrauterine insemination (IUI) until 14-16 weeks' gestation. The rate of PE was significantly lower in the study group compared to control group (8.4% vs. 14.2%, p<0.05). Women supplemented with dydrogesterone only showed a lower PE incidence as compared to women received a combination of dydrogesterone and hydroxyprogesterone caproate, however, it was not statistically significant (6.9% vs. 9.9%; 6.9%; p=0.2).

Original languageEnglish
Pages (from-to)93-96
Number of pages4
JournalHormone Molecular Biology and Clinical Investigation
Volume27
Issue number3
DOIs
Publication statusPublished - 1 Sep 2016

Fingerprint

Dydrogesterone
Assisted Reproductive Techniques
Pre-Eclampsia
Progesterone
Pregnancy
Control Groups
Maternal Mortality
Insemination
Incidence
Progestins
Research Design
Age Groups
Morbidity

Keywords

  • in vitro fertilisation
  • intrauterine insemination
  • luteal phase
  • pre-eclampsia
  • progesterone

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)
  • Molecular Biology
  • Endocrinology

Cite this

@article{c114544edfd649d983fb99ffd43a8629,
title = "Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia",
abstract = "Pre-eclampsia (PE) contributes to poor maternal morbidity and mortality. Progesterone is hypothesised to reduce the risk of PE. To determine the effect of progestogen supplementation during assisted reproductive technique (ART) in reducing the incidence of PE. A retrospective comparative analysis among 1140 pregnancies between January 2006 and March 2015 conducted in a tertiary centre. A total of 570 pregnancies who conceived following ART with progesterone supplementation (study group) and an age-matched spontaneous pregnancies, without progesterone supplementation (control group, n=570) were included in the analysis. The study group received progesterone support following ART or intrauterine insemination (IUI) until 14-16 weeks' gestation. The rate of PE was significantly lower in the study group compared to control group (8.4{\%} vs. 14.2{\%}, p<0.05). Women supplemented with dydrogesterone only showed a lower PE incidence as compared to women received a combination of dydrogesterone and hydroxyprogesterone caproate, however, it was not statistically significant (6.9{\%} vs. 9.9{\%}; 6.9{\%}; p=0.2).",
keywords = "in vitro fertilisation, intrauterine insemination, luteal phase, pre-eclampsia, progesterone",
author = "Ali Anizah and Ahmad, {Mohd Faizal B} and Ng, {Beng Kwang} and Lim, {Pei Shan} and Shafiee, {Mohamad Nasir} and Omar, {Mohd Hashim}",
year = "2016",
month = "9",
day = "1",
doi = "10.1515/hmbci-2015-0063",
language = "English",
volume = "27",
pages = "93--96",
journal = "Hormone Molecular Biology and Clinical Investigation",
issn = "1868-1883",
publisher = "Walter de Gruyter GmbH",
number = "3",

}

TY - JOUR

T1 - Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia

AU - Anizah, Ali

AU - Ahmad, Mohd Faizal B

AU - Ng, Beng Kwang

AU - Lim, Pei Shan

AU - Shafiee, Mohamad Nasir

AU - Omar, Mohd Hashim

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Pre-eclampsia (PE) contributes to poor maternal morbidity and mortality. Progesterone is hypothesised to reduce the risk of PE. To determine the effect of progestogen supplementation during assisted reproductive technique (ART) in reducing the incidence of PE. A retrospective comparative analysis among 1140 pregnancies between January 2006 and March 2015 conducted in a tertiary centre. A total of 570 pregnancies who conceived following ART with progesterone supplementation (study group) and an age-matched spontaneous pregnancies, without progesterone supplementation (control group, n=570) were included in the analysis. The study group received progesterone support following ART or intrauterine insemination (IUI) until 14-16 weeks' gestation. The rate of PE was significantly lower in the study group compared to control group (8.4% vs. 14.2%, p<0.05). Women supplemented with dydrogesterone only showed a lower PE incidence as compared to women received a combination of dydrogesterone and hydroxyprogesterone caproate, however, it was not statistically significant (6.9% vs. 9.9%; 6.9%; p=0.2).

AB - Pre-eclampsia (PE) contributes to poor maternal morbidity and mortality. Progesterone is hypothesised to reduce the risk of PE. To determine the effect of progestogen supplementation during assisted reproductive technique (ART) in reducing the incidence of PE. A retrospective comparative analysis among 1140 pregnancies between January 2006 and March 2015 conducted in a tertiary centre. A total of 570 pregnancies who conceived following ART with progesterone supplementation (study group) and an age-matched spontaneous pregnancies, without progesterone supplementation (control group, n=570) were included in the analysis. The study group received progesterone support following ART or intrauterine insemination (IUI) until 14-16 weeks' gestation. The rate of PE was significantly lower in the study group compared to control group (8.4% vs. 14.2%, p<0.05). Women supplemented with dydrogesterone only showed a lower PE incidence as compared to women received a combination of dydrogesterone and hydroxyprogesterone caproate, however, it was not statistically significant (6.9% vs. 9.9%; 6.9%; p=0.2).

KW - in vitro fertilisation

KW - intrauterine insemination

KW - luteal phase

KW - pre-eclampsia

KW - progesterone

UR - http://www.scopus.com/inward/record.url?scp=84990058928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990058928&partnerID=8YFLogxK

U2 - 10.1515/hmbci-2015-0063

DO - 10.1515/hmbci-2015-0063

M3 - Article

C2 - 26910749

AN - SCOPUS:84990058928

VL - 27

SP - 93

EP - 96

JO - Hormone Molecular Biology and Clinical Investigation

JF - Hormone Molecular Biology and Clinical Investigation

SN - 1868-1883

IS - 3

ER -